IP Library Granted Patent US 8,951,800
Granted Patent B2
US 8,951,800 · App. 12/710,078 · Granted Feb 10, 2015

Primate pluripotent stem cell expansion without feeder cells and in the presence of FGF and matrigel or Engelbreth-Holm-Swarm tumor cell preparation

Inventors: Ramkumar Mandalam (Union City, CA); Chunhui Xu (Cupertino, CA); Joseph D. Gold (San Francisco, CA); Melissa K. Carpenter (Castro Valley, CA)
Assignee: Asterias Biotherapeutics, Inc.
C12N15/1096C12N5/0606C12N5/0619C12N5/0622C12N15/1034C12N5/0696C12N5/0068C12N5/0678C12N2500/99C12N2501/105C12N2533/50C12N11/04C12N2501/065C12N5/0603C12N2500/98C12N5/0693C12N5/0062C12N5/0662C12N5/0671C12N5/0075C12N5/0692C12N5/068C12N5/0607C12N2501/998C12N5/0672C12N2500/25C12N2501/115C12N2501/119C12N2501/125C12N2501/13C12N2501/145C12N2501/155C12N2501/2306C12N2501/235C12N2501/237C12N2501/26C12N2502/99C12N2503/02C12N2506/02C12N2510/00C12N2510/04C12N2533/90C12N2502/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,951,800
App. No.
12/710,078
Granted
Feb 10, 2015
Kind
B2
Abstract

This disclosure provides an improved system for culturing human pluripotent stem cells. Traditionally, pluripotent stem cells are cultured on a layer of feeder cells (such as mouse embryonic fibroblasts) to prevent them from differentiating. In the system described here, the role of feeder cells is replaced by components added to the culture environment that support rapid proliferation without differentiation. Effective features are a suitable support structure for the cells, and an effective medium that can be added fresh to the culture without being preconditioned by another cell type. Culturing human embryonic stem cells in fresh medium according to this invention causes the cells to expand surprisingly rapidly, while retaining the ability to differentiate into cells representing all three embryonic germ layers. This new culture system allows for bulk proliferation of pPS cells for commercial production of important products for use in drug screening and human therapy.

Claims (8)

1. A system for expanding primate pluripotent stem cells in vitro without feeder cells comprising a nutrient media comprising primate pluripotent stem cells, a fibroblast growth factor and a soluble preparation from Engelbreth-Holm-Swarm tumor cells.

2. The system of claim 1 , wherein the nutrient media is conditioned by a feeder cell.

3. The system of claim 1 , wherein the nutrient media is a fresh media that is not conditioned by a feeder cell.

4. A system for expanding a cell expressing the markers stage specific antigen 4 (SSEA4), Tra-I-60 and Tra-1-81 in vitro without feeder cells comprising a cell expressing the markers stage specific antigen 4 (SSEA4), Tra-I-60 and Tra-1-81, a nutrient media comprising a fibroblast growth factor and a soluble preparation from Engelbreth-Holm-Swarm tumor cells.

5. A method of culturing primate pluripotent stem cells in vitro without feeder cells comprising culturing the primate pluripotent stem cells on a soluble preparation from Engelbreth-Holm-swarm tumor cells and contacting the cells with a nutrient media comprising a fibroblast growth factor.

6. The method of claim 5 , wherein the nutrient media is conditioned by a feeder cell.

7. The method of claim 5 , wherein the nutrient media is a fresh media that is not conditioned by a feeder cell.

8. A method of culturing a cell expressing the markers, stage specific antigen 4 (SSEA4), Tra-1-60 and Tra-1-81 in vitro without feeder cells comprising culturing the cell expressing the markers, stage specific antigen 4 (SSEA4), Tra-1-60 and Tra-1-81 on a soluble preparation from Engelbreth-Holm-Swarm tumor cells and contacting the cell with a nutrient media comprising a fibroblast growth factor.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 11, 2013
From: GERON CORPORATION
To: ASTERIAS BIOTHERAPEUITCS, INC.
Reel/Frame 031578/0054 →
Continuity (13)
Continuation 12170219 · Jul 9, 2008
Continuation 10235094 · Sep 4, 2002
Continuation In Part 10948956 · Sep 24, 2004
Continuation In Part 09530346
Continuation In Part 10235094 · Sep 4, 2002
Continuation In Part 09849022 · May 4, 2001
Provisional Application 60317478 · Sep 5, 2001
Provisional Application 60220064 · Jul 21, 2000
Provisional Application 60216387 · Jul 7, 2000
Provisional Application 60213739 · Jun 22, 2000
Provisional Application 60213740 · Jun 22, 2000
Related Publication 20100317101A1 · Dec 16, 2010
Related Publication 20140302600A9 · Oct 9, 2014